Alnylam Pharmaceuticals
ALNY
#486
Rank
C$68.02 B
Marketcap
C$514.90
Share price
-6.87%
Change (1 day)
38.31%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company